enVVeno Medical Corporation
NASDAQ: NVNO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Robert A. Berman
- Employees
- 37
- Headquarters
- Irvine, United States
- IPO year
- 2018
- Market cap
- $187.6K
- Website
- https://www.envveno.com
Loading NVNO…
Loading profile data…Frequently asked questions about NVNO
What does enVVeno Medical Corporation (NVNO) do?
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from veno...
Where does NVNO trade?
enVVeno Medical Corporation (NVNO) trades on the NASDAQ Capital Market.
What sector is NVNO in?
enVVeno Medical Corporation (NVNO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of enVVeno Medical Corporation?
Robert A. Berman is the chief executive officer of enVVeno Medical Corporation (NVNO).
Where is enVVeno Medical Corporation headquartered?
enVVeno Medical Corporation is headquartered in United States.
Does NVNO pay a dividend?
enVVeno Medical Corporation (NVNO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVNO go public?
enVVeno Medical Corporation (NVNO) completed its initial public offering in 2018.